Advertisement

Topics

PharmaMar presents positive results with ADC MI130110 in CD13-expressing tumor cells

19:00 EST 30 Nov 2016 | AAAS

(Pharmamar) PharmaMar, a world leader in the discovery, development and commercialization of new anti-tumor compounds of a marine origin, has announced that its antibody-drug conjugate (ADC) has demonstrated a remarkable in vitro antitumoral activity in a CD13, fibrosarcoma positive animal model.

Original Article: PharmaMar presents positive results with ADC MI130110 in CD13-expressing tumor cells

NEXT ARTICLE

More From BioPortfolio on "PharmaMar presents positive results with ADC MI130110 in CD13-expressing tumor cells"

Quick Search
Advertisement
 

Relevant Topics

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...